Generex Biotechnology Corp: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
678540.00 |
| Income |
-42.25 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
-200.41% |
| Debt/Equity Ratio |
0.11 |
|
| Revenue/Share |
0.00 |
| Earnings/Share |
-0.27 |
| Book Value/Share |
0.11 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (07/10) | FY (07/09) | FY (07/08) |
|---|
| 1st Qtr | 0.1 | 0.5 | 0.0 |
| 2nd Qtr | NA | 0.4 | 0.0 |
| 3rd Qtr | NA | 0.0 | 0.0 |
| 4th Qtr | NA | 0.1 | 0.1 |
| Total | 0.1 | 1.1 | 0.1 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (07/10) | FY (07/09) | FY (07/08) |
|---|
| 1st Qtr | -$0.03 | -$0.10 | -$0.07 |
| 2nd Qtr | NA | -$0.10 | -$0.06 |
| 3rd Qtr | NA | -$0.08 | -$0.09 |
| 4th Qtr | NA | -$0.06 | -$0.11 |
| Total | -$0.03 | -$0.34 | -$0.33 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (07/10) | FY (07/09) | FY (07/08) |
|---|
| 1st Qtr | 50% | 9% | --- |
| 2nd Qtr | NA | 0% | 14% |
| 3rd Qtr | NA | 20% | -50% |
| 4th Qtr | NA | 25% | -22% |
| Yr. over Yr. EPS Growth Rate |
| FY (07/10) | FY (07/09) |
|---|
| 1st Qtr | 70% | -43% |
| 2nd Qtr | NA | -67% |
| 3rd Qtr | NA | 11% |
| 4th Qtr | NA | 45% |
advertisement
Recent News